1-3 of 3
Chisa Wada
Close
Sort by
Journal Articles

EZH1/2 Dual Inhibitor Valemetostat Tosylate (DS-3201b) Acts Differently from EZH2 Selective Inhibitor on Epigenetic Landscape to Exert Greater Anti-Tumor Effect Against Diffuse Large B-Cell Lymphoma

Toshihiro Banjo, Yasuhiro Hama, Emi Nosaka, Yoshimi Takata, Daisuke Honma, Mayumi Kitagawa, Yuka Yamamoto, Chisa Wada, Takanori Yoshida, Kyungtaek Lim, Atsushi Okamoto, Erina Sato, Yumiko Katayama, Kazumi Sato, Hiroki Goto, Yuki Abe
Journal: Blood
Blood (2021) 138 (Supplement 1): 2948.
https://doi.org/10.1182/blood-2021-146772
Published: 2021
Journal Articles

Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways

Yasuhiro Hama, PhD, Toshihiro Banjo, PhD, Daisuke Honma, PhD, Yoshimi Takata, Emi Nosaka, Machiko Shiroishi, Kenji Watanabe, Yuka Yamamoto, Tsuyoshi Hirata, Rika Nakano, Koichiro Inaki, PhD, Hiroki Goto, PhD, Yusuke Totoki, PhD, Miki Kataoka, Kyungtaek Lim, PhD, Chisa Wada, Eiji Kumazawa, PhD, Shinji Tsutsumi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4642.
https://doi.org/10.1182/blood-2019-125436
Published: 2019
Journal Articles

Novel Stem Cell-Targeted Therapy for Multiple Myeloma Based on Dual Inhibition of EZH1/2

Makoto Nakagawa, MD, Shuhei Fujita, MD BS, Daisuke Honma, PhD, Kazushi Araki, D.V.M., PhD, Tatsuya Inoue, Ayako Kato, Koichiro Inaki, PhD, Chisa Wada, Ono Yoshimasa, Yasuharu Nakashima, MDPhD, Issay Kitabayashi, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 590.
https://doi.org/10.1182/blood.V130.Suppl_1.590.590
Published: 2017